{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:35:19Z","timestamp":1761744919864,"version":"3.37.3"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"22","license":[{"start":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T00:00:00Z","timestamp":1549238400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1038\/s41388-019-0717-6","type":"journal-article","created":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T12:04:20Z","timestamp":1549281860000},"page":"4264-4282","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["A novel proteotoxic combination therapy for EGFR+ and HER2+ cancers"],"prefix":"10.1038","volume":"38","author":[{"given":"Mengxiong","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renan B.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary E.","family":"Law","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley J.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elham","family":"Yaaghubi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda F.","family":"Ghilardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhisheak","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bonnie A.","family":"Avery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edgardo","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Wu","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satya","family":"Narayan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Coy D.","family":"Heldermon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald K.","family":"Castellano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8411-6531","authenticated-orcid":false,"given":"Brian K.","family":"Law","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,4]]},"reference":[{"key":"717_CR1","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1093\/jnci\/djt043","volume":"105","author":"RT Chlebowski","year":"2013","unstructured":"Chlebowski RT, Manson JE, Anderson GL, Cauley JA, Aragaki AK, Stefanick ML, et al. Estrogen plus progestin and breast cancer incidence and mortality in the Women\u2019s Health Initiative Observational Study. J Natl Cancer Inst. 2013;105:526\u201335.","journal-title":"J Natl Cancer Inst"},{"key":"717_CR2","doi-asserted-by":"publisher","first-page":"4907","DOI":"10.1182\/blood-2005-08-3531","volume":"107","author":"EA Obeng","year":"2006","unstructured":"Obeng EA, Carlson LM, Gutman DM, Harrington WJ Jr., Lee KP, Boise LH. Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells. Blood. 2006;107:4907\u201316.","journal-title":"Blood"},{"key":"717_CR3","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.critrevonc.2018.05.003","volume":"127","author":"M Wang","year":"2018","unstructured":"Wang M, Law ME, Castellano RK, Law BK. The unfolded protein response as a target for anticancer therapeutics. Crit Rev Oncol\/Hematol. 2018;127:66\u201379.","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"717_CR4","doi-asserted-by":"publisher","first-page":"23086","DOI":"10.1074\/jbc.M114.570911","volume":"289","author":"P Stocki","year":"2014","unstructured":"Stocki P, Chapman DC, Beach LA, Williams DB. Depletion of cyclophilins B and C leads to dysregulation of endoplasmic reticulum redox homeostasis. J Biol Chem. 2014;289:23086\u201396.","journal-title":"J Biol Chem"},{"key":"717_CR5","doi-asserted-by":"publisher","first-page":"9622","DOI":"10.1021\/acs.jmedchem.6b00411","volume":"59","author":"BM Dunyak","year":"2016","unstructured":"Dunyak BM, Gestwicki JE. Peptidyl-proline isomerases (PPIases): targets for natural products and natural product-inspired compounds. J Med Chem. 2016;59:9622\u201344.","journal-title":"J Med Chem"},{"key":"717_CR6","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.coph.2011.03.007","volume":"11","author":"M Theuerkorn","year":"2011","unstructured":"Theuerkorn M, Fischer G, Schiene-Fischer C. Prolyl cis\/trans isomerase signalling pathways in cancer. Curr Opin Pharmacol. 2011;11:281\u20137.","journal-title":"Curr Opin Pharmacol"},{"key":"717_CR7","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.4161\/cc.22222","volume":"11","author":"MB Werneck","year":"2012","unstructured":"Werneck MB, Hottz E, Bozza PT, Viola JP. Cyclosporin A inhibits colon cancer cell growth independently of the calcineurin pathway. Cell Cycle. 2012;11:3997\u20134008.","journal-title":"Cell Cycle"},{"key":"717_CR8","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1038\/onc.2012.174","volume":"32","author":"IA Ciechomska","year":"2013","unstructured":"Ciechomska IA, Gabrusiewicz K, Szczepankiewicz AA, Kaminska B. Endoplasmic reticulum stress triggers autophagy in malignant glioma cells undergoing cyclosporine a-induced cell death. Oncogene. 2013;32:1518\u201329.","journal-title":"Oncogene"},{"key":"717_CR9","doi-asserted-by":"publisher","first-page":"6978","DOI":"10.1074\/jbc.M117.780742","volume":"292","author":"PJ Robinson","year":"2017","unstructured":"Robinson PJ, Pringle MA, Woolhead CA, Bulleid NJ. Folding of a single domain protein entering the endoplasmic reticulum precedes disulfide formation. J Biol Chem. 2017;292:6978\u201386.","journal-title":"J Biol Chem"},{"key":"717_CR10","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.cell.2010.06.011","volume":"141","author":"MA Lemmon","year":"2010","unstructured":"Lemmon MA, Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell. 2010;141:1117\u201334.","journal-title":"Cell"},{"key":"717_CR11","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/S0092-8674(02)00963-7","volume":"110","author":"H Ogiso","year":"2002","unstructured":"Ogiso H, Ishitani R, Nureki O, Fukai S, Yamanaka M, Kim JH, et al. Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains. Cell. 2002;110:775\u201387.","journal-title":"Cell"},{"key":"717_CR12","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/S1097-2765(03)00048-0","volume":"11","author":"TP Garrett","year":"2003","unstructured":"Garrett TP, McKern NM, Lou M, Elleman TC, Adams TE, Lovrecz GO, et al. The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors. Mol Cell. 2003;11:495\u2013505.","journal-title":"Mol Cell"},{"key":"717_CR13","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/nature01392","volume":"421","author":"HS Cho","year":"2003","unstructured":"Cho HS, Mason K, Ramyar KX, Stanley AM, Gabelli SB, Denney DW Jr., et al. Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab. Nature. 2003;421:756\u201360.","journal-title":"Nature"},{"key":"717_CR14","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1126\/science.1074611","volume":"297","author":"HS Cho","year":"2002","unstructured":"Cho HS, Leahy DJ. Structure of the extracellular region of HER3 reveals an interdomain tether. Science. 2002;297:1330\u20133.","journal-title":"Science"},{"key":"717_CR15","doi-asserted-by":"publisher","first-page":"10445","DOI":"10.18632\/oncotarget.3398","volume":"6","author":"RB Ferreira","year":"2015","unstructured":"Ferreira RB, Law ME, Jahn SC, Davis BJ, Heldermon CD, Reinhard M, et al. Novel agents that downregulate EGFR, HER2, and HER3 in parallel. Oncotarget. 2015;6:10445\u201359.","journal-title":"Oncotarget"},{"key":"717_CR16","doi-asserted-by":"publisher","first-page":"28971","DOI":"10.18632\/oncotarget.15952","volume":"8","author":"RB Ferreira","year":"2017","unstructured":"Ferreira RB, Wang M, Law ME, Davis BJ, Bartley AN, Higgins PJ, et al. Disulfide bond disrupting agents activate the unfolded protein response in EGFR- and HER2-positive breast tumor cells. Oncotarget. 2017;8:28971\u201389.","journal-title":"Oncotarget"},{"key":"717_CR17","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s10549-009-0674-9","volume":"123","author":"B Gyorffy","year":"2010","unstructured":"Gyorffy B, Lanczky A, Eklund AC, Denkert C, Budczies J, Li Q, et al. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res Treat. 2010;123:725\u201331.","journal-title":"Breast Cancer Res Treat"},{"key":"717_CR18","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1021\/ja00159a059","volume":"112","author":"RP Iyer","year":"1990","unstructured":"Iyer RP, Egan W, Regan JB, Beaucage SL. 3h-1,2-Benzodithiole-3-One 1,1-Dioxide as an improved sulfurizing reagent in the solid-phase synthesis of oligodeoxyribonucleoside phosphorothioates. J Am Chem Soc. 1990;112:1253\u20134.","journal-title":"J Am Chem Soc"},{"key":"717_CR19","doi-asserted-by":"publisher","first-page":"4196","DOI":"10.1021\/jo00798a055","volume":"37","author":"PK Srivastava","year":"1972","unstructured":"Srivastava PK, Field L. Organic disulfides and related substances .36. some oxodisulfide cleavage reactions to form disulfides and trisulfides. J Org Chem. 1972;37:4196\u20138.","journal-title":"J Org Chem"},{"key":"717_CR20","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1021\/jo01292a032","volume":"45","author":"SW Bass","year":"1980","unstructured":"Bass SW, Evans SA. C-13 Nuclear magnetic-resonance spectral properties of alkyl disulfides, thiolsulfinates, and thiolsulfonates. J Org Chem. 1980;45:710\u20135.","journal-title":"J Org Chem"},{"key":"717_CR21","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/bscb.19690780305","volume":"78","author":"EJ Goethals","year":"1969","unstructured":"Goethals EJ, Huylebro J, Smolders W. Synthesis of thiosultones. B Soc Chim Belg. 1969;78:191\u2013&.","journal-title":"B Soc Chim Belg"},{"key":"717_CR22","first-page":"6","volume":"Unit 7","author":"DA Hartman","year":"2003","unstructured":"Hartman DA. Determination of the stability of drugs in plasma. Curr Protoc Pharmacol. 2003;Unit 7:6. Chapter 7","journal-title":"Curr Protoc Pharmacol"},{"key":"717_CR23","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","volume":"70","author":"TC Chou","year":"2010","unstructured":"Chou TC. Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res. 2010;70:440\u20136.","journal-title":"Cancer Res"},{"key":"717_CR24","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S0171-2985(89)80062-2","volume":"178","author":"T Shimizu","year":"1989","unstructured":"Shimizu T, Martin MS, Pelletier H, Lagadec P, Martin F. Effects of cyclosporin A on progressive and regressive tumors induced by two cancer lines derived from a single colon carcinoma chemically induced in the rat. Immunobiology. 1989;178:401\u201315.","journal-title":"Immunobiology"},{"key":"717_CR25","first-page":"23","volume":"Unit14","author":"YS DeRose","year":"2013","unstructured":"DeRose YS, Gligorich KM, Wang G, Georgelas A, Bowman P, Courdy SJ, et al. Patient-derived models of human breast cancer: protocols for in vitro and in vivo applications in tumor biology and translational medicine. Curr Protoc Pharmacol. 2013;Unit14:23. Chapter 14","journal-title":"Curr Protoc Pharmacol"},{"key":"717_CR26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3233\/BD-1999-11105","volume":"11","author":"L Neckers","year":"2000","unstructured":"Neckers L. Effects of geldanamycin and other naturally occurring small molecule antagonists of heat shock protein 90 on HER2 protein expression. Breast Dis. 2000;11:49\u201359.","journal-title":"Breast Dis"},{"key":"717_CR27","first-page":"3307","volume":"35","author":"M Takenokuchi","year":"2015","unstructured":"Takenokuchi M, Miyamoto K, Saigo K, Taniguchi T, Bortezomib Causes ER. Stress-related death of acute promyelocytic leukemia cells through excessive accumulation of PML-RARA. Anticancer Res. 2015;35:3307\u201316.","journal-title":"Anticancer Res"},{"key":"717_CR28","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.ccell.2015.10.002","volume":"28","author":"DJ Anderson","year":"2015","unstructured":"Anderson DJ, Le Moigne R, Djakovic S, Kumar B, Rice J, Wong S, et al. Targeting the AAA ATPase p97 as an approach to treat cancer through disruption of protein homeostasis. Cancer Cell. 2015;28:653\u201365.","journal-title":"Cancer Cell"},{"key":"717_CR29","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3389\/fonc.2016.00181","volume":"6","author":"PH Vekaria","year":"2016","unstructured":"Vekaria PH, Home T, Weir S, Schoenen FJ, Rao R. Targeting p97 to disrupt protein homeostasis in cancer. Front Oncol. 2016;6:181.","journal-title":"Front Oncol"},{"key":"717_CR30","doi-asserted-by":"publisher","first-page":"5321","DOI":"10.1073\/pnas.89.12.5321","volume":"89","author":"OP Kallioniemi","year":"1992","unstructured":"Kallioniemi OP, Kallioniemi A, Kurisu W, Thor A, Chen LC, Smith HS, et al. ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization. Proc Natl Acad Sci USA. 1992;89:5321\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"717_CR31","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1021\/jm00273a024","volume":"15","author":"L Field","year":"1972","unstructured":"Field L, Khim YH. Organic disulfides and related substances. 33. sodium 4-(2-acetamidoethyldithio)butanesulfinate and related compounds as antiradiation drugs. J Med Chem. 1972;15:312\u20135.","journal-title":"J Med Chem"},{"key":"717_CR32","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.4045\/tidsskr.10.0862","volume":"131","author":"J Hysing","year":"2011","unstructured":"Hysing J, Wist E. Cardiotoxic effects of trastuzumab. Tidsskr Nor Laege. 2011;131:2239\u201341.","journal-title":"Tidsskr Nor Laege"},{"key":"717_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12253-008-9018-z","volume":"14","author":"L Kopper","year":"2008","unstructured":"Kopper L. Lapatinib: a sword with two edges. Pathol Oncol Res. 2008;14:1\u20138.","journal-title":"Pathol Oncol Res"},{"key":"717_CR34","doi-asserted-by":"publisher","first-page":"28450","DOI":"10.1074\/jbc.M606054200","volume":"281","author":"E Erdogan","year":"2006","unstructured":"Erdogan E, Lamark T, Stallings-Mann M, Lee J, Pellecchia M, Thompson EA, et al. Aurothiomalate inhibits transformed growth by targeting the PB1 domain of protein kinase Ciota. J Biol Chem. 2006;281:28450\u20139.","journal-title":"J Biol Chem"},{"key":"717_CR35","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.exphem.2013.11.010","volume":"42","author":"X Feng","year":"2014","unstructured":"Feng X, Holmlund T, Zheng C, Fadeel B. Proapoptotic effects of the novel proteasome inhibitor b-AP15 on multiple myeloma cells and natural killer cells. Exp Hematol. 2014;42:172\u201382.","journal-title":"Exp Hematol"},{"key":"717_CR36","doi-asserted-by":"publisher","first-page":"ra52","DOI":"10.1126\/scisignal.aaa6922","volume":"8","author":"N Singh","year":"2015","unstructured":"Singh N, Joshi R, Komurov K. HER2-mTOR signaling-driven breast cancer cells require ER-associated degradation to survive. Sci Signal. 2015;8:ra52.","journal-title":"Sci Signal"},{"key":"717_CR37","doi-asserted-by":"publisher","first-page":"5295","DOI":"10.1021\/jm9008295","volume":"52","author":"S Ni","year":"2009","unstructured":"Ni S, Yuan Y, Huang J, Mao X, Lv M, Zhu J, et al. Discovering potent small molecule inhibitors of cyclophilin A using de novo drug design approach. J Med Chem. 2009;52:5295\u20138.","journal-title":"J Med Chem"},{"key":"717_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12777","volume":"7","author":"A Ahmed-Belkacem","year":"2016","unstructured":"Ahmed-Belkacem A, Colliandre L, Ahnou N, Nevers Q, Gelin M, Bessin Y, et al. Fragment-based discovery of a new family of non-peptidic small-molecule cyclophilin inhibitors with potent antiviral activities. Nat Commun. 2016;7:12777.","journal-title":"Nat Commun"},{"key":"717_CR39","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1593\/neo.07112","volume":"9","author":"DR Rhodes","year":"2007","unstructured":"Rhodes DR, Kalyana-Sundaram S, Mahavisno V, Varambally R, Yu J, Briggs BB, et al. Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia. 2007;9:166\u201380.","journal-title":"Neoplasia"},{"key":"717_CR40","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1039\/C3PP50333J","volume":"13","author":"AD Garg","year":"2014","unstructured":"Garg AD, Agostinis P. ER stress, autophagy and immunogenic cell death in photodynamic therapy-induced anti-cancer immune responses. Photochem Photobiol Sci. 2014;13:474\u201387.","journal-title":"Photochem Photobiol Sci"},{"key":"717_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-016-0741-1","volume":"18","author":"ME Law","year":"2016","unstructured":"Law ME, Ferreira RB, Davis BJ, Higgins PJ, Kim JS, Castellano RK, et al. CUB domain-containing protein 1 and the epidermal growth factor receptor cooperate to induce cell detachment. Breast Cancer Res. 2016;18:80.","journal-title":"Breast Cancer Res"},{"key":"717_CR42","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.ajpath.2011.10.036","volume":"180","author":"X Liu","year":"2012","unstructured":"Liu X, Ory V, Chapman S, Yuan H, Albanese C, Kallakury B, et al. ROCK inhibitor and feeder cells induce the conditional reprogramming of epithelial cells. Am J Pathol. 2012;180:599\u2013607.","journal-title":"Am J Pathol"},{"key":"717_CR43","doi-asserted-by":"publisher","first-page":"38261","DOI":"10.1074\/jbc.M005545200","volume":"275","author":"BK Law","year":"2000","unstructured":"Law BK, Waltner-Law ME, Entingh AJ, Chytil A, Aakre ME, Norgaard P, et al. Salicylate-induced growth arrest is associated with inhibition of p70s6k and down-regulation of c-myc, cyclin D1, cyclin A, and proliferating cell nuclear antigen. J Biol Chem. 2000;275:38261\u20137.","journal-title":"J Biol Chem"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41388-019-0717-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41388-019-0717-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41388-019-0717-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:15:27Z","timestamp":1684617327000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-019-0717-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,4]]},"references-count":43,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["717"],"URL":"https:\/\/doi.org\/10.1038\/s41388-019-0717-6","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"type":"print","value":"0950-9232"},{"type":"electronic","value":"1476-5594"}],"subject":[],"published":{"date-parts":[[2019,2,4]]},"assertion":[{"value":"31 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}